← All decks
The first 25 slides, exactly as they appear. The full deck has 183 content slides.
General Surgery
Laparoscopic Staging and Approaches to Cancer
Built from Maingot's Abdominal Operations
What’s inside
9 sections · 183 slides
Rationale for laparoscopic staging
What the procedure is, and the gap in imaging it fills
- Definition of laparoscopic staging
- Cancers assessed by laparoscopic staging
- Aims of a staging procedure
- Limits of noninvasive imaging
- What laparoscopy adds to imaging
- Laparoscopic staging alongside other modalities
- Effect of a positive laparoscopy on care
Technique of laparoscopic staging
Access, the systematic survey, washings and ultrasound
- Timing and setting of the procedure
- Anaesthesia and patient positioning
- Equipment for laparoscopic staging
- Access to the peritoneal cavity
- Access after previous abdominal surgery
- Establishing pneumoperitoneum
- Port placement for staging laparoscopy
- Sequence of the peritoneal survey
- Examination of the liver
- Indirect palpation of the liver surface
- Biopsy of a suspicious liver lesion
- Electrosurgical coupling injuries
- Examination of the porta hepatis
- Assessment of the duodenum and bile duct
- Inspection of the transverse mesocolon
- Tumour infiltration of the colonic mesocolon
- Entering the lesser sac
- Incision of the omentum to enter the lesser sac
- The gastric pillar and coeliac axis
- Hepatic artery and gastric pillar in the lesser sac
- Peritoneal lavage cytology
- Working with the cytologist
- Rationale for laparoscopic ultrasound
- Laparoscopic ultrasound probes
- Scanning the liver with ultrasound
- Superficial liver metastasis on ultrasound
- Ultrasound of the biliary tree and pancreas
- Retropancreatic structures on laparoscopic ultrasound
Oesophageal carcinoma
Where imaging stops and laparoscopy starts
- Burden and outlook in oesophageal cancer
- Diagnostic modalities for staging oesophagogastric cancers
- Comparative roles of EUS, CT and FDG-PET
- Endoscopy and endoscopic palliation
- Multislice CT for oesophageal staging
- Endoscopic ultrasonography for TNM staging
- Accuracy and cost of EUS with fine-needle aspiration
- Uptake of EUS-FNA in practice
- FDG-PET and the primary tumour
- Uptake value and depth of tumour invasion
- FDG-PET after chemoradiotherapy
- FDG-PET for metastases and restaging
- FDG-PET/CT for radiotherapy planning
- Occult disease remaining after imaging
- Value of laparoscopy in oesophageal cancer
- Laparoscopy compared with endoscopic ultrasound
- The largest staging laparoscopy series
- Tumour site and yield of laparoscopy
- Explanation for the site effect
- Adding laparoscopic ultrasound in oesophagogastric cancer
- Combined endoscopic and laparoscopic ultrasound
- Yield by histology and the authors' recommendation
Gastric cancer
Occult peritoneal disease, and what the washings say
- Changing epidemiology of gastric cancer
- Outcome and the reasons for it
- Staging tools in gastric cancer
- Treatment algorithm for gastric cancer
- Yield of laparoscopy in gastric cancer
- Accuracy of nodal and T staging
- Peritoneal metastasis in gastric cancer
- Diagnostic performance of staging laparoscopy
- Upstaging and change of treatment plan
- Limits of modern CT for peritoneal disease
- Positive peritoneal cytology as a prognostic marker
- Cytology conversion after chemotherapy
- Cytology as an independent predictor of death
- Combining peritoneal deposits with cytology
- Newcastle disease virus for free cancer cells
- Sensitivity of the virus method by stage
- Laparoscopy in early gastric cancer
Liver and gallbladder cancer
Selecting who benefits, with a clinical risk score
- What makes liver disease unresectable
- Rationale for laparoscopy before liver resection
- Memorial Sloan-Kettering experience
- Comparison with straight-to-laparotomy patients
- Larger follow-up analysis
- Clinical risk score for resectability in hepatic colorectal disease
- Using the clinical risk score
- Validation of the clinical risk score
- Staging after previous colectomy
- Adding intraoperative and laparoscopic ultrasound
- Isolated liver metastasis on laparoscopic ultrasound
- Ultrasound-guided biopsy of liver lesions
- Clinical impact of ultrasound-guided biopsy
- Ultrasound compared with MRI for resectability
- Hepatocellular carcinoma
- Laparoscopy as a treatment platform in liver cancer
- Ultrasound and ablation in cirrhosis
- Noncolorectal, nonneuroendocrine liver metastases
- Gallbladder and biliary cancer
Pancreas cancer
The largest evidence base, and the sharpest disagreement
- Outlook in pancreatic adenocarcinoma
- Rationale for laparoscopic staging in pancreatic cancer
- Gains from avoiding an unnecessary laparotomy
- Origins of laparoscopic staging
- “
- Quality of the preoperative CT scan
- Effect on resectability rates
- Criteria for unresectability at laparoscopy
- Hepatic metastases from pancreatic cancer
- Venous involvement and resectability
- Outcome of the Memorial Sloan-Kettering series
- Contemporary yield of staging laparoscopy
- Doran periampullary series
- Detection of intraabdominal metastases at laparoscopy
- Carbohydrate antigen 19-9 as a selection tool
- Optimal CA 19-9 cut-off
- Treatment algorithm for pancreas cancer
- Population-based evidence for selective use
- Adding laparoscopic ultrasound in pancreatic cancer
- Where ultrasound changes the plan
- Resection rates with and without ultrasound
- Coeliac axis and splenic artery infiltration on ultrasound
- Grading vascular involvement on CT
- Meta-analysis of laparoscopy and ultrasound
- Peritoneal cytology in pancreatic cancer
- Predictive value of positive peritoneal cytology
- Molecular detection in peritoneal washings
- Arguments against routine laparoscopy
- Selective strategies in current practice
- Laparoscopy in locally advanced disease
- Further series in locally advanced disease
- Nonductal and periampullary tumours
Complications and port-site recurrence
How safe the procedure is, and what a port-site implant means
- Safety of staging laparoscopy
- Early concern about port-site implants
- Reported port-site recurrence rates
- Comparison with open wound recurrence
- What a port-site recurrence signifies
- Proposed mechanisms of port-site implantation
Laparoscopic biliary and gastric bypass
Palliating jaundice and gastric outlet obstruction
- Need for palliation in pancreatic cancer
- Choice of biliary bypass
- Laparoscopic cholecystojejunostomy
- Selecting patients for cholecystojejunostomy
- When cholecystojejunostomy is not possible
- Early laparoscopic palliation series
- Laparoscopic compared with open palliation
- Comparative data on gastrojejunostomy
- Single-incision gastrojejunostomy
- Incidence of gastric outlet obstruction
- Delayed gastric emptying without obstruction
- Need for later bypass after staging laparoscopy
- Positioning and ports for bypass
- Bringing the jejunal loop to the gallbladder
- Jejunal loop brought up to the gallbladder
- Approximating bowel to gallbladder
- Making the enterotomies
- Creating the enterotomies for the anastomosis
- Firing the linear stapler
- Stapled cholecystojejunal anastomosis
- Checking and closing the anastomosis
- Intracorporeal closure of the enterotomy
- Hand-sewn and assisted alternatives
- Result of the assisted technique
- Technique for gastrojejunostomy
- Creating and closing the gastrojejunal anastomosis
- Completed laparoscopic gastrojejunostomy
- Goals of a palliative procedure
Summary and references
Where laparoscopic staging stands today
- Summary of the role of laparoscopy
- Points to carry away
- References
- References (continued)
- References (continued)
- References (continued)
- References (continued)
- References (continued)
- References (continued)
- References (continued)
- References (continued)
- References (continued)
- References (continued)
- References (continued)
- References (continued)
- References (continued)
- References (continued)
- References (continued)
- References (continued)
- References (continued)
- References (continued)
- References (continued)
- References (continued)
- Maingot's Abdominal Operations, 12th Edition